Press "Enter" to skip to content

New patent for Astrazeneca Ab drug BYDUREON BCISE

0
Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Ab drug BYDUREON BCISE

Annual Drug Patent Expirations for BYDUREON+BCISE
Annual Drug Patent Expirations for BYDUREON+BCISE

Bydureon Bcise is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are twenty-one patents protecting this drug.

BYDUREON BCISE drug price trends.

Drug patent litigation for BYDUREON BCISE.

This drug has four hundred and fifty-eight patent family members in forty-eight countries.

The generic ingredient in BYDUREON BCISE is exenatide. One supplier is listed for this compound. Additional details are available on the exenatide profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Astrazeneca Ab drug BYDUREON BCISE
    Get the DrugPatentWatch Daily Briefing

    ✓ Patent Expirations and Generic Entry

    ✓ Insightful Articles & Case Studies

    ✓ Patent Litigation & Challenges

    ✓ 505(b)(2) & Biosimilars

    ✓ Industry Trends

    Do NOT follow this link or you will be banned from the site!